Investor Relations & Capital Introduction in Rehovot

Rehovot is a city south of Tel Aviv and home to one of the world's leading scientific research institutes. For founders, it offers world-class science, agricultural research and a strong technology transfer culture.

Why Rehovot Matters for Capital Raising

The Weizmann Institute of Science in Rehovot is one of the world's leading multidisciplinary research institutes.

Yeda, Weizmann's technology transfer company founded in 1959, has commercialised discoveries that led to major drugs and technologies.

The Hebrew University's Faculty of Agriculture in Rehovot supports a strong agritech and food technology sector.

What Rehovot Investors Examine

For deep tech and life sciences companies, scientific strength and commercial pathway are examined closely.

Investors value experienced management and strong intellectual property.

The Rehovot Startup and Investor Ecosystem

Rehovot's innovation economy grows out of its research campuses rather than a traditional business district. Laboratories at the Weizmann Institute and the agricultural faculty generate a steady pipeline of spinouts, and many young companies stay close to the scientists who founded them, taking space in the Kiryat Weizmann Science Park on the edge of the city.

The local mix is distinctive: drug discovery, diagnostics, plant genetics, crop protection, alternative proteins and advanced materials sit alongside one another. Kaplan Medical Center adds a clinical setting for health technology work, and the surrounding towns of the coastal plain host food producers and agricultural cooperatives that act as early customers and testbeds.

Rehovot is only a short train ride from Tel Aviv, so its founders draw on the venture funds, corporate innovation teams and international investors concentrated there while keeping their research base in a quieter scientific town.

Investor Types Active in Rehovot

Life sciences venture funds, agrifood specialists and corporate venture arms of global pharmaceutical, seed and food groups are the most active backers of Rehovot companies. Angel investors with scientific backgrounds often write the first cheques, and cross-border investors from the United States and Europe join later rounds. They tend to value licensed intellectual property, a credible regulatory route and founding teams that combine research depth with commercial leadership.

Engagement and Access

GCN connects founders with Rehovot investors and the wider Tel Aviv and international investor communities through conference programming and private sessions.

Sectors where we see consistent Rehovot interest include life sciences and biotech, agritech and food technology, deep tech and materials, AI and medical devices.

Partner with Global Capital Network

Whether you are raising into Rehovot or allocating from it, our team can discuss how our investor relations infrastructure applies to your objectives.